SCANPHARM A/S: Financial statements 2025
CVR: 16279099
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
SCANPHARM A/S (CVR 16279099) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 29,716,677 and a net result of DKK 962,722 compared with DKK 582,684 the year before. That is an increase of 10.5% compared with the year before. Equity in the 2025 report amounted to DKK 3,045,406. The solvency ratio was 7.8%.
- Gross Profit
- DKK 29,716,677
- Profit/Loss
- DKK 962,722
- Equity
- DKK 3,045,406
- Total Assets
- DKK 39,207,452
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 29.7 mio. | 963 t. | 3 mio. | 0 |
| 2024 | - | 26.9 mio. | 583 t. | 2.1 mio. | 42 |
| 2023 | - | 22.5 mio. | -4.4 mio. | 1.5 mio. | 44 |
| 2022 | - | 17.4 mio. | -6 mio. | 1.5 mio. | 41 |
| 2021 | - | 11.3 mio. | -10.9 mio. | 1.5 mio. | 40 |
Official annual report
How creditworthy is SCANPHARM A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
SCANPHARM A/S has published its annual report for 2024. Gross profit came to DKK 26,903,798, and the net result was DKK 582,684.
About SCANPHARM A/S
SCANPHARM A/S is a Danish company of the type Aktieselskab based in Birkerød, founded in 1992. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named SCANPHARM A/S AF 1992 and A/S SCANPHARM AF 1992. The management consists of Andreas Bjørn Jensen. The board consists of Janus Doré Pagh (chair), Andreas Bjørn Jensen and Hanne Bjørn Jensen. The company is owned by CHLOPETHAN A/S and Peluli Holding ApS. The company has 42 employees (2026). In 2025, the company reported a gross profit of DKK 29,716,677 and a net result of DKK 962,722 compared with DKK 582,684 the year before. Equity in the 2025 report amounted to DKK 3,045,406.